A multi-center, stratification-randomized, double-blind, placebo-controlled, phase III clinical trial of topical recombinant human thrombin for intraoperative hemostasis

被引:0
|
作者
Yan, Sheng [1 ]
Yu, Jun [2 ]
Tu, Chaoyong [3 ]
Du, Chengyou [4 ]
Luo, Jia [5 ]
Liu, Jingfeng [6 ]
Liu, Tian-Qi [7 ]
Liu, Qiang [8 ]
Liu, Jun [9 ]
Li, Xuehua [10 ]
Wang, Lianchen [11 ]
Fang, Zheping [12 ]
Yi, Weimin [13 ]
Chen, Yajin [14 ]
Li, Qinglong [15 ]
Ni, Yong [16 ]
Wu, Jincai [17 ]
Qin, Changjiang [18 ]
Gu, Yuanlong [19 ]
Lu, Zheng [20 ]
Lun, Zengjun [21 ]
Du, Lixue [22 ]
Chen, Gang [23 ]
Zheng, Qichang [24 ]
Zhu, Ling [25 ]
Sun, KeJian [26 ]
Han, Weiqing [5 ]
机构
[1] Zhejiang Univ, Sch Med, Hosp 2, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sch Med, Hosp 1, Hangzhou, Peoples R China
[3] Lishui Cent Hosp, Lishui, Peoples R China
[4] Chongqing Med Univ, Affiliated Hosp 1, Chongqing, Peoples R China
[5] Hunan Canc Hosp, Changsha, Peoples R China
[6] Fujian Med Univ, Mengchao Hepatobiliary Hosp, Fuzhou, Peoples R China
[7] Jiangbin Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China
[8] Liuzhou Peoples Hosp, Liuzhou, Peoples R China
[9] Guizhou Prov Peoples Hosp, Guiyang, Peoples R China
[10] Liaocheng Peoples Hosp, Liaocheng, Peoples R China
[11] Third Peoples Hosp Hainan Prov, Sanya, Peoples R China
[12] Taizhou Hosp Zhejiang Prov, Taizhou, Peoples R China
[13] Hunan Prov Peoples Hosp, Changsha, Peoples R China
[14] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China
[15] Cent South Univ, Xiangya Hosp 2, Changsha, Peoples R China
[16] Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China
[17] Hainan Prov Peoples Hosp, Haikou, Peoples R China
[18] Henan Univ, Huaihe Hosp, Kaifeng, Peoples R China
[19] Third Peoples Hosp Wuxi, Wuxi, Peoples R China
[20] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[21] Zaozhuang Municipal Hosp, Zaozhuang, Peoples R China
[22] Shaanxi Prov Peoples Hosp, Xian, Peoples R China
[23] First Peoples Hosp Kunming, Kunming, Peoples R China
[24] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Wuhan, Peoples R China
[25] Wuhan Cent Hosp, Wuhan, Peoples R China
[26] Zibo Cent Hosp, Zibo, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-540
引用
收藏
页码:S488 / S488
页数:1
相关论文
共 50 条
  • [1] Efficacy of Huadananshen mistura on insomnia: a randomized, double-blind, placebo-controlled, and multi-center clinical trial
    Huafang Li
    Xiaoli Yan
    Ting Li
    Jian Xu
    Qiaochu Wang
    Yifeng Xu
    Journal of Traditional Chinese Medicine, 2013, 33 (04) : 423 - 427
  • [2] Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
    Shengyuan Yu
    Ye Ran
    Wei Xiao
    Wenjing Tang
    Jianjun Zhao
    Wei Chen
    Huikui Zhuang
    Cun Ouyang
    Hai Lin
    Dequan Liu
    Tongjun Chen
    Hui Huang
    Baoshen Wang
    Yanlei Hao
    Zhongrui Yan
    Shike Zhao
    Yanling Wang
    Jinjun Ni
    Chaodong Wang
    Wentao Ding
    Guoqian Li
    Jianhua Cao
    Shujuan Tian
    BMC Complementary and Alternative Medicine, 19
  • [3] Efficacy of Huadananshen mistura on insomnia: a randomized, double-blind, placebo-controlled, and multi-center clinical trial
    Li, Huafang
    Yan, Xiaoli
    Li, Ting
    Xu, Jian
    Wang, Qiaochu
    Xu, Yifeng
    JOURNAL OF TRADITIONAL CHINESE MEDICINE, 2013, 33 (04) : 423 - 427
  • [4] Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial
    Yu, Shengyuan
    Ran, Ye
    Xiao, Wei
    Tang, Wenjing
    Zhao, Jianjun
    Chen, Wei
    Zhuang, Huikui
    Ouyang, Cun
    Lin, Hai
    Liu, Dequan
    Chen, Tongjun
    Huang, Hui
    Wang, Baoshen
    Hao, Yanlei
    Yan, Zhongrui
    Zhao, Shike
    Wang, Yanling
    Ni, Jinjun
    Wang, Chaodong
    Ding, Wentao
    Li, Guoqian
    Cao, Jianhua
    Tian, Shujuan
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 19 (01):
  • [5] Gemcitabine/cisplatin plus bevacizumab or placebo in advanced malignant mesothelioma: A multi-center, double-blind, placebo-controlled, randomized phase III trial
    Kindler, H
    Lu, C
    Gandara, D
    Stevenson, J
    Krug, L
    Janne, P
    Gitlitz, B
    Karrison, T
    Stadler, W
    Vokes, E
    LUNG CANCER, 2005, 49 : S28 - S29
  • [6] Chinese Herbs For Acute Asthma: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
    Wang, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [7] A Phase Iii Multi-Center, Randomized, Placebo-Controlled, Double-Blind Clinical Trial To Evaluate The Efficacy And Safety Of Desloratadine In Japanese Patients With Chronic Urticaria
    Hisada, S.
    Imai, Y.
    Oshima, N.
    Tanaka, Y.
    Weinstein, C. I.
    Hide, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] PRE-surgical Metformin In Uterine Malignancy (PREMIUM): a Multi-Center, Randomized Double-Blind, Placebo-Controlled Phase III Trial
    Kitson, Sarah J.
    Maskell, Zoe
    Sivalingam, Vanitha N.
    Allen, Jennifer L.
    Ali, Saad
    Burns, Sean
    Gilmour, Kyle
    Latheef, Rahamatulla
    Slade, Richard J.
    Pemberton, Philip W.
    Shaw, Joseph
    Ryder, W. David
    Kitchener, Henry C.
    Crosbie, Emma J.
    CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2424 - 2432
  • [9] Topical Treatment Is Effective and Safe for Acute Ankle Sprains: The Multi-Center Double-Blind Randomized Placebo-Controlled TRAUMED Trial
    Gerdesmeyer, Ludger
    Vester, Johannes
    Schneider, Christian
    Wildemann, Britt
    Frank, Christine
    Schultz, Myron
    Seilheimer, Bernd
    Smit, Alta
    Kerkhoffs, Gino
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (03)
  • [10] Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial
    Lu, LG
    Zeng, MD
    Mao, YM
    Li, JQ
    Wan, MB
    Li, CZ
    Chen, CW
    Fu, QC
    Wang, JY
    She, WM
    Cai, X
    Ye, J
    Zhou, XQ
    Wang, H
    Wu, SM
    Tang, MF
    Zhu, JS
    Chen, WX
    Zhang, HQ
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (11) : 2480 - 2483